Myrna Nahas
- Co-authors
- David AviganJacalyn RosenblattHillard M. LazarusDina StroopinskyJon ArnasonDonald KüfeSalvia JainAthalia R. Pyzer
- Topics
- CAR-T cell therapy research (15 papers)Immunotherapy and Immune Responses (12 papers)Lymphoma Diagnosis and Treatment (5 papers)
- Cited by
- HematologyOncologyImmunology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Myrna Nahas
30 papers receiving 145 citations
Peers
Comparison fields: 5 of 34
- Oncology 80
- Immunology 61
- Molecular Biology 60
- Hematology 46
- Pathology and Forensic Medicine 20
Countries citing papers authored by Myrna Nahas
This map shows the geographic impact of Myrna Nahas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myrna Nahas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myrna Nahas more than expected).
Fields of papers citing papers by Myrna Nahas
This network shows the impact of papers produced by Myrna Nahas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myrna Nahas. The network helps show where Myrna Nahas may publish in the future.
Co-authorship network of co-authors of Myrna Nahas
This figure shows the co-authorship network connecting the top 25 collaborators of Myrna Nahas. A scholar is included among the top collaborators of Myrna Nahas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myrna Nahas. Myrna Nahas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 20 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 23 | |
| 15 | 16 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 4 | |
| 19 | 2 | |
| 20 | 2 |
About Myrna Nahas
Myrna Nahas is a scholar working on Immunology, Oncology and Hematology, having authored 33 papers that have together received 146 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (12 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (46 citations), Oncology (80 citations) and Immunology (61 citations). Myrna Nahas has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include David Avigan, Jacalyn Rosenblatt, Hillard M. Lazarus, Dina Stroopinsky, Jon Arnason, Donald Küfe, Salvia Jain, Athalia R. Pyzer, Rebecca Karp Leaf and Arie Apel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.